Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03450070 · ClinicalTrials.gov registry record · NA
Repeat Insult Patch Test APPENDIX I to HRL Standard Protocol #100
A NA study of Allergic Sensitization, sponsored by Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies.
- Completed
- Registry status
- NA
- Development phase
- 121
- Enrollment target
- 1
- Study location
NCT03450070 is a NA study of Allergic Sensitization that has completed, run by Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies. The registered enrollment target is 121 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03450070, a NA study of Allergic Sensitization, has completed, sponsored by Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies.
- COMPLETED
- Registry status
- NA
- Development phase
- 121 participants
- Enrollment target
- 1
- Study location
Study Summary
Patch Testing for device cream on human subjects
Conditions Studied
Interventions
- DEVICE Light Therapy Mask Cream
Study Locations (1)
New Jersey
- Harrison Research Laboratories - Union
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2017-11-15 |
| Est. Completion | 2017-12-22 |
| Phase | NA |
Sponsor
Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies4 total trials
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03450070
The ClinicalTrials.gov registry entry for NCT03450070 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Allergic Sensitization appearing as the primary indexed condition, and to 1 intervention - of which Light Therapy Mask Cream is the first listed.
NCT03450070 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT03450070 about?
NCT03450070 is a clinical study titled "Repeat Insult Patch Test APPENDIX I to HRL Standard Protocol #100". Patch Testing for device cream on human subjects
What is the current status of trial NCT03450070?
This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2017-11-15. Estimated completion is 2017-12-22.
What conditions does trial NCT03450070 study?
This clinical trial studies the following conditions: Allergic Sensitization.
What interventions are being tested in trial NCT03450070?
The interventions under investigation include: Light Therapy Mask Cream (DEVICE).
Who is sponsoring clinical trial NCT03450070?
This trial is sponsored by Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03450070 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.